Reuters exclusively reported S.Korea’s GL Rapha to ship out 10 mln Sputnik Light COVID-19 shots this month

Reuters exclusively reported that South Korean biotech firm GL Rapha expects to win regulatory approval from Russia to export Sputnik Light coronavirus vaccines this month, paving the way for the first overseas production of the shot to ease a supply shortage. The Russian Direct Investment Fund, which markets Sputnik V and single-dose version Sputnik Light abroad, plans to produce around 700 million doses overseas this year. But production got off to a slow start and growing domestic demand constrained supply from Russia, disrupting both shots’ global rollout plan and allowing rival vaccine makers to fill the gap in several markets.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Asia
Countries: RussiaSouth Korea
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story
Sign up for email updates

Sign up for email updates